(Q40161327)

18 September 2017

Immune intervention at diagnosis--should we treat children to preserve beta-cell function? (English)

1 reference

18 September 2017

1

1 reference

18 September 2017

1 October 2007

1 reference

18 September 2017

1 reference

18 September 2017

8 Suppl 6

1 reference

18 September 2017

34-39

1 reference

beta-cell function in children with diabetes

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

C-peptide is a bioactive peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Insulin prophylaxis in individuals at high risk of type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

The immunological effect of photopheresis in children with newly diagnosed type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00299.X

10.1111/J.1399-5448.2007.00299.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

17727383